Cerebrolysin
Neuropeptide mixture that supports brain recovery and cognitive function
Clinical Research Score: 4/5 — Backed by numerous randomized controlled trials and meta-analyses for stroke and dementia; approved in many countries but not the US.
Categories: Mental / Cognitive
What is Cerebrolysin?
Cerebrolysin occupies a unique position — it's one of the few brain-health compounds with extensive clinical data from real hospital settings. Used in numerous countries for stroke recovery and traumatic brain injury, it delivers a cocktail of neuropeptides that essentially feed and repair the brain.
People report profound cognitive benefits. Those recovering from brain injuries describe accelerated recovery of memory, speech, and cognitive function. Those using it for general brain optimization report enhanced memory, sharper focus, and improved mental stamina. The effects tend to build over a treatment course of 10-20 days.
What makes Cerebrolysin compelling is the depth of evidence. We're not talking about anecdotal reports alone — there are published clinical trials showing measurable improvements in cognitive function across multiple neurological conditions. It's the kind of compound that bridges the gap between wellness optimization and clinical neurology.
How Cerebrolysin works
Cerebrolysin delivers a mixture of low-molecular-weight neuropeptides that mimic the brain's own growth factors. These peptides promote neurogenesis (the birth of new brain cells), synaptogenesis (the formation of new connections between neurons), and reduce neuroinflammation. They provide BDNF-like activity — essentially the same growth signals your brain uses to build and maintain neural networks. The result is a brain that's actively building, repairing, and strengthening its circuitry.
Scientific overview
Cerebrolysin is a mixture of low-molecular-weight neuropeptides and free amino acids derived from porcine brain tissue. It has neurotrophic properties similar to naturally occurring nerve growth factors. Clinical studies have demonstrated its efficacy in stroke recovery, traumatic brain injury, and Alzheimer's disease, with improvements in cognitive function and neural plasticity.
Dosing
- Starting dose: 5 mL per day
- Common dosage range: 5-30 mL per day (IV/IM)
- Administration: Intramuscular, Intravenous
- Half-life: ~60 minutes
- Frequency: Daily for 10-20 day treatment courses